KIT and chronic myelogenous leukemia, BCR-ABL1 positive: IMA, a protein tyrosine kinase Bcr-Abl and c-KIT selective inhibitor, is used for the treatment of gastrointestinal stromal tumors and chronic myeloid leukemia [54,55].